C. Byrne and G. Targher, NAFLD: A multisystem disease, Journal of Hepatology, vol.62, issue.1, pp.47-64, 2015.
DOI : 10.1016/j.jhep.2014.12.012

D. Tiniakos, M. Vos, and E. Brunt, Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis, Annual Review of Pathology: Mechanisms of Disease, vol.5, issue.1, pp.145-71, 2010.
DOI : 10.1146/annurev-pathol-121808-102132

P. Angulo, D. Kleiner, S. Dam-larsen, L. Adams, E. Bjornsson et al., Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease, Gastroenterology, vol.149, issue.2, pp.389-397, 2015.
DOI : 10.1053/j.gastro.2015.04.043

H. Yi and W. Jeong, Interaction of hepatic stellate cells with diverse types of immune cells: Foe or friend?, Journal of Gastroenterology and Hepatology, vol.27, issue.Suppl. 2, pp.99-104, 2013.
DOI : 10.1111/j.1440-1746.2011.07007.x

P. Marvie, M. Lisbonne, L. 'helgoualc-'h, A. Rauch, M. Turlin et al., Interleukin-33 overexpression is associated with liver fibrosis in mice and humans, Journal of Cellular and Molecular Medicine, vol.190, issue.6b, pp.1726-1765, 2010.
DOI : 10.4049/jimmunol.173.6.4020
URL : https://hal.archives-ouvertes.fr/hal-00660257

T. Mchedlidze, M. Waldner, S. Zopf, J. Walker, A. Rankin et al., Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis, Immunity, vol.39, issue.2, pp.357-71, 2013.
DOI : 10.1016/j.immuni.2013.07.018

M. Arshad, C. Piquet-pellorce, L. Helgoualc-'h, A. Rauch, M. Patrat-delon et al., TRAIL but not FasL and TNF??, regulates IL-33 expression in murine hepatocytes during acute hepatitis, Hepatology, vol.31, issue.Suppl 1, pp.2353-62, 2012.
DOI : 10.1016/j.immuni.2009.06.011

M. Arshad, M. Rauch, L. 'helgoualc-'h, A. Julia, V. Leite-de-moraes et al., NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis, European Journal of Immunology, vol.41, issue.8, pp.2341-2389, 2011.
DOI : 10.1002/eji.201041006
URL : https://hal.archives-ouvertes.fr/hal-00681990

M. Arshad, P. Guihard, Y. Danger, G. Noel, L. Seyec et al., lymphocytes, American Journal of Physiology-Gastrointestinal and Liver Physiology, vol.93, issue.7, pp.542-53, 2015.
DOI : 10.1016/j.jhep.2005.04.020
URL : https://hal.archives-ouvertes.fr/hal-01220632

N. Martin and M. Martin, Interleukin 33 is a guardian of barriers and a local alarmin, Nature Immunology, vol.2014, issue.2, pp.122-153, 2016.
DOI : 10.1371/journal.pone.0011944

Y. Choi, J. Park, J. Kim, S. Rho, H. Park et al., Nuclear IL-33 is a transcriptional regulator of NF-??B p65 and induces endothelial cell activation, Biochemical and Biophysical Research Communications, vol.421, issue.2, pp.305-316, 2012.
DOI : 10.1016/j.bbrc.2012.04.005

C. Cayrol and J. Girard, IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy, Current Opinion in Immunology, vol.31, pp.31-37, 2014.
DOI : 10.1016/j.coi.2014.09.004

O. Rostan, M. Arshad, C. Piquet-pellorce, F. Robert-gangneux, J. Gangneux et al., Crucial and Diverse Role of the Interleukin-33/ST2 Axis in Infectious Diseases, Infection and Immunity, vol.83, issue.5, pp.1738-1786, 2015.
DOI : 10.1128/IAI.02908-14

Y. Gao, Y. Liu, M. Yang, X. Guo, M. Zhang et al., IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis, Oncotarget, vol.7, issue.23, pp.33649-61, 2016.
DOI : 10.18632/oncotarget.9259

D. Ballak, R. Stienstra, C. Tack, C. Dinarello, and J. Van-diepen, IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance, Cytokine, vol.75, issue.2, pp.280-90, 2015.
DOI : 10.1016/j.cyto.2015.05.005

N. Matsuzawa, T. Takamura, S. Kurita, H. Misu, T. Ota et al., Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet, Hepatology, vol.24, issue.5, pp.1392-403, 2007.
DOI : 10.1002/hep.510240532

P. Vasseur, L. Serres, J. Jégou, M. Pohin, A. Delwail et al., High-Fat Diet???Induced IL-17A Exacerbates Psoriasiform Dermatitis in a Mouse Model of Steatohepatitis, The American Journal of Pathology, vol.186, issue.9, pp.2292-301, 2016.
DOI : 10.1016/j.ajpath.2016.05.012
URL : https://hal.archives-ouvertes.fr/hal-01703902

D. Benson, M. Mendez, J. Engel, . Jr, S. Signer et al., com/oncotarget 19 Affective symptomatology in epilepsy, Int J Neurol, vol.1920, pp.30-39, 1985.

K. Mak, A. Kwong, E. Chu, and N. Hoo, Hepatic Steatosis, Fibrosis, and Cancer in Elderly Cadavers, The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology, vol.254, issue.1, pp.40-50, 2012.
DOI : 10.1001/jama.1985.03360050065027

G. Noel, M. Arshad, A. Filliol, V. Genet, M. Rauch et al., regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration, American Journal of Physiology-Gastrointestinal and Liver Physiology, vol.311, issue.2, pp.313-336, 2016.
DOI : 10.1111/imr.12163
URL : https://hal.archives-ouvertes.fr/hal-01366372

T. Wynn, Type 2 cytokines: mechanisms and therapeutic strategies, Nature Reviews Immunology, vol.278, issue.5, pp.271-82, 2015.
DOI : 10.1016/j.cell.2014.03.066

J. Lott, T. Sumpter, and H. Turnquist, New dog and new tricks: evolving roles for IL-33 in type 2 immunity, Journal of Leukocyte Biology, vol.133, issue.Suppl 1, pp.1037-1085, 2015.
DOI : 10.1016/j.jaci.2014.01.002

J. Han, D. Wu, H. Denroche, Y. Yao, C. Verchere et al., T Regulatory Cells and Ameliorates Adipose Tissue Inflammation and Insulin Resistance, The Journal of Immunology, vol.194, issue.10, pp.4777-83, 2015.
DOI : 10.4049/jimmunol.1500020

A. Miller, D. Asquith, A. Hueber, L. Anderson, W. Holmes et al., Interleukin-33 Induces Protective Effects in Adipose Tissue Inflammation During Obesity in Mice, Circulation Research, vol.107, issue.5, pp.650-58, 2010.
DOI : 10.1161/CIRCRESAHA.110.218867

S. Ibrahim, P. Hirsova, H. Malhi, and G. Gores, Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame, Digestive Diseases and Sciences, vol.92, issue.5, pp.1325-1361, 2016.
DOI : 10.1007/s00109-014-1170-1

L. Hebbard and J. George, Animal models of nonalcoholic fatty liver disease, Nature Reviews Gastroenterology & Hepatology, vol.134, issue.1, pp.35-44, 2011.
DOI : 10.1002/hep.23535

S. Ali, A. Mohs, M. Thomas, J. Klare, R. Ross et al., The Dual Function Cytokine IL-33 Interacts with the Transcription Factor NF-??B To Dampen NF-??B-Stimulated Gene Transcription, The Journal of Immunology, vol.187, issue.4, pp.1609-1625, 2011.
DOI : 10.4049/jimmunol.1003080

D. Shao, F. Perros, G. Caramori, C. Meng, P. Dormuller et al., Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension, Biochemical and Biophysical Research Communications, vol.451, issue.1, pp.8-14, 2014.
DOI : 10.1016/j.bbrc.2014.06.111

P. Martin, G. Palmer, E. Rodriguez, E. Woldt, I. Mean et al., Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling, Immunity, Inflammation and Disease, vol.39, issue.3, pp.239-285, 2015.
DOI : 10.2337/diab.39.10.1158

A. Miller, D. Xu, D. Asquith, L. Denby, Y. Li et al., IL-33 reduces the development of atherosclerosis, The Journal of Experimental Medicine, vol.209, issue.2, pp.339-385, 2008.
DOI : 10.1006/mthe.2001.0424

M. Arshad, H. Khan, G. Noel, C. Piquet-pellorce, and M. Samson, Potential Therapeutic Aspects of Alarmin Cytokine Interleukin 33 or Its Inhibitors in Various Diseases, Clinical Therapeutics, vol.38, issue.5, pp.1000-1016, 2016.
DOI : 10.1016/j.clinthera.2016.02.021
URL : https://hal.archives-ouvertes.fr/hal-01295637

A. Vasanthakumar, K. Moro, A. Xin, Y. Liao, R. Gloury et al., The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue???resident regulatory T cells, Nature Immunology, vol.460, issue.3, pp.276-85, 2015.
DOI : 10.3109/01902148.2013.870261

K. Neumann, K. Karimi, J. Meiners, R. Voetlause, S. Steinmann et al., A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis, The Journal of Immunology, vol.2014, issue.1, pp.128-165, 2017.
DOI : 10.1038/ni.3085

J. Hua, X. Ma, T. Webb, J. Potter, M. Oelke et al., Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease, Journal of Lipid Research, vol.16, issue.7, pp.1696-703, 2010.
DOI : 10.1089/1096620041224157

Z. Li, M. Soloski, and A. Diehl, Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease, Hepatology, vol.24, issue.4, pp.880-85, 2005.
DOI : 10.4049/jimmunol.171.4.1775

T. Tang, Y. Sui, M. Lian, Z. Li, and J. Hua, Pro-Inflammatory Activated Kupffer Cells by Lipids Induce Hepatic NKT Cells Deficiency through Activation-Induced Cell Death, PLoS ONE, vol.21, issue.12, p.81949, 2013.
DOI : 10.1371/journal.pone.0081949.g008

T. Miyagi, T. Takehara, A. Uemura, K. Nishio, S. Shimizu et al., Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet, Journal of Gastroenterology, vol.68, issue.12, pp.1247-54, 2010.
DOI : 10.3748/wjg.v13.i33.4504

W. Syn, Y. Oo, T. Pereira, G. Karaca, Y. Jung et al., Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease, Hepatology, vol.153, issue.6, pp.1998-2007, 2010.
DOI : 10.4049/jimmunol.181.7.4656

M. Pichery, E. Mirey, P. Mercier, E. Lefrancais, A. Dujardin et al., Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33-LacZ Gene Trap Reporter Strain, The Journal of Immunology, vol.188, issue.7, pp.3488-95, 2012.
DOI : 10.4049/jimmunol.1101977

M. Fujii, Y. Shibazaki, K. Wakamatsu, Y. Honda, Y. Kawauchi et al., A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma, Medical Molecular Morphology, vol.351, issue.Suppl 3, pp.141-52, 2013.
DOI : 10.1016/S0140-6736(05)78493-2

D. Kleiner, E. Brunt, M. Van-natta, C. Behling, M. Contos et al., Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, vol.38, issue.6, pp.1313-1334, 2005.
DOI : 10.1002/hep.20701

J. Diana, L. Beaudoin, A. Gautron, A. Lehuen, . Nkt et al., NKT and Tolerance, Methods Mol Biol, vol.677, pp.193-206, 2011.
DOI : 10.1007/978-1-60761-869-0_14

M. Lisbonne, L. Helgoualc-'h, A. Nauwelaers, G. Turlin, B. Lucas et al., Invariant natural killer T-cell-deficient mice display increased CCl4-induced hepatitis associated with CXCL1 over-expression and neutrophil infiltration, European Journal of Immunology, vol.34, issue.6, pp.1720-1752, 2011.
DOI : 10.1002/eji.200324828
URL : https://hal.archives-ouvertes.fr/hal-00681993